| Date Filed | Type | Description |
| 10/11/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/13/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/06/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/01/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/31/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/10/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/28/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/03/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/04/2022 |
4
| CANAAN X L.P. (10% Owner) has filed a Form 4 on Astra Space, Inc.|
Txns:
| Disposed of 4,200,000 shares
@ $0 |
|
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/22/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/19/2021 |
3
| CANAAN X L.P. (10% Owner) has filed a Form 3 on Astra Space, Inc. |
| 05/03/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/02/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/26/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/10/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/11/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/27/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/23/2020 |
4
| CANAAN X L.P. (10% Owner) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted options to buy
@ $2000000, valued at
$0 |
|
| 05/28/2019 |
4
| CANAAN X L.P. (10% Owner) has filed a Form 4 on IDEAYA Biosciences, Inc.|
Txns:
| Converted 1,658,164 shares
@ $0
Converted 602,549 shares
@ $0
Bought 400,000 shares
@ $10, valued at
$4M
Converted 1,658,164 preferred shares
@ $0
Converted 602,549 preferred shares
@ $0 |
|
| 05/22/2019 |
3
| CANAAN X L.P. (10% Owner) has filed a Form 3 on IDEAYA Biosciences, Inc. |
| 05/13/2019 |
4
| CANAAN X L.P. (10% Owner) has filed a Form 4 on NextCure, Inc.|
Txns:
| Converted 445,866 shares
@ $0
Converted 743,110 shares
@ $0
Converted 729,599 shares
@ $0
Converted 285,867 shares
@ $0
Bought 50,000 shares
@ $15, valued at
$750k
Converted 3,582,000 preferred shares
@ $0
Converted 5,970,000 preferred shares
@ $0
Converted 5,861,455 options to buy
@ $0
Converted 2,296,605 preferred shares
@ $0 |
|
| 05/08/2019 |
3
| CANAAN X L.P. (10% Owner) has filed a Form 3 on NextCure, Inc. |
| 05/30/2018 |
4
| CANAAN X L.P. (10% Owner) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Converted 721,408 shares
@ $0
Converted 275,446 shares
@ $0
Converted 229,660 shares
@ $0
Bought 506,656 shares
@ $13, valued at
$6.6M
Converted 721,408 options to buy
@ $0
Converted 275,446 options to buy
@ $0
Converted 229,660 options to buy
@ $0 |
|
| 05/24/2018 |
3
| CANAAN X L.P. (10% Owner) has filed a Form 3 on Iterum Therapeutics plc |
| 05/21/2018 |
4
| CANAAN X L.P. (10% Owner) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Sold 38,968 shares
@ $6.0911, valued at
$237.4k
|
|
| 05/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2018 |
4
| CANAAN X L.P. (10% Owner) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Sold 59,950 shares
@ $20.706, valued at
$1.2M
|
|
| 03/22/2018 |
4
| CANAAN X L.P. (10% Owner) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Sold 17,060 shares
@ $20.606, valued at
$351.5k
Sold 17,699 shares
@ $20.6072, valued at
$364.7k
Sold 4,759 shares
@ $20.6205, valued at
$98.1k
|
|
| 03/19/2018 |
4
| CANAAN X L.P. (10% Owner) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Sold 6,926 shares
@ $20.5115, valued at
$142.1k
Sold 13,439 shares
@ $20.5704, valued at
$276.4k
|
|
| 03/15/2018 |
4
| CANAAN X L.P. (10% Owner) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Sold 1,204 shares
@ $20.842, valued at
$25.1k
Sold 200 shares
@ $20.77, valued at
$4.2k
Sold 11,751 shares
@ $20.6383, valued at
$242.5k
|
|
| 08/16/2016 |
4
| CANAAN X L.P. (10% Owner) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Converted 1,869,922 shares
@ $0
Bought 583,333 shares
@ $12, valued at
$7M
Converted 27,113,877 preferred shares
@ $0 |
|
| 08/10/2016 |
3
| CANAAN X L.P. (10% Owner) has filed a Form 3 on Protagonist Therapeutics, Inc |